Eli Lilly and Company vs AstraZeneca PLC
Side-by-side stock comparison based on AI earnings call analysis
| Metric | Eli Lilly and Company | AstraZeneca PLC |
|---|---|---|
| Current Price | ₹1,126.8 | ₹185.33 |
| Market Cap | ₹10.61 L Cr. | ₹5.75 L Cr. |
| Industry | Pharmaceuticals | Pharmaceuticals |
| P/E Ratio | 37.87762 | 28.148872 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 1 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |
